---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-019075"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T15:14:01.982197+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCA Q4 net income $1.81B ($5.75 EPS); guides 2022 rev $60-62B; $8B buyback

## Summary
- Revenue $15.064B, net income $1.814B (diluted EPS $5.75) vs $1.426B ($4.13) in Q4 2020.
- Adjusted EBITDA $3.149B in Q4; 2022 guidance: rev $60-62B, adj EBITDA $12.55-13.05B, EPS $18.40-19.20.
- Board authorized additional $8B share repurchase program; $586M remaining under prior authorization as of Dec 31.
- Quarterly dividend declared at $0.56 per share, payable March 31, 2022.
- Andrea B. Smith appointed independent director, increasing board to 11; serves on audit and patient safety committees.

## SEC filing metadata
- accession: 0001193125-22-019075
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312522019075/0001193125-22-019075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312522019075/d292652d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-019075
- JSON: https://secwatch.observer/filing/0001193125-22-019075.json
- Plain text: https://secwatch.observer/filing/0001193125-22-019075.txt

## Key facts
- Executive change
  Andrea B. Smith was appointed as director at HCA Healthcare, Inc..
  - Action: appointed
  source text: On January 24, 2022, the Company’s Board of Directors (the “Board”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Andrea B. Smith to the Company’s Board effective January 26, 2022, increasing the number of directors on the Board from 10 to 11.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312522019075/0001193125-22-019075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.